Cardiovascular and cerebrovascular diseases are one of the most serious diseases threatening humanity today, with incidence and mortality rates that have surpassed those of cancer to become the highest in the world. Vascular thrombosis is one of the major causes of cardiovascular diseases. However, with the advent of an aging society, the number of patients with thrombotic diseases is expected to increase further, posing a great threat to the health and medical economy of our country's residents. As a product for the prevention of cardiovascular and cerebrovascular diseases that has been widely used globally for 20 years, the advantages of nattokinase in dissolving blood clots, regulating blood pressure, and promoting blood circulation in the human body have gained international consensus.

Nattokinase is a natural enzyme, also known as subtilisin or QK fibrinolytic enzyme, and is an optimal nutrient for smooth blood flow. A healthy blood flow index refers to normal blood viscosity or thickness. Fibrin, which has a hemostatic effect, determines the viscosity of the blood. Plasmin is an enzyme that can help decompose fibrin, allowing blood to flow normally. The rate at which plasmin is produced in the body slows down with age. Nattokinase has a function similar to plasmin, which can decompose fibrin and also stimulate the body to naturally produce plasmin, helping to support normal blood circulation, flow, and blood viscosity.

With the increase in research and application of nattokinase's thrombolytic effects, the advantages of nattokinase in preventing cardiovascular and cerebrovascular diseases have gained international consensus:

1. Easy absorption by the human body: The relative molecular weight of nattokinase is only 27,728, far less than other bioactive enzymes such as urokinase (with a molecular weight of about 50,000 to 60,000), making it easy to be absorbed by the human body and produce better effects.

2. High thrombolytic efficiency: The fibrinolytic activity of nattokinase is about four times that of plasmin, and the thrombolytic speed is 19 times that of urokinase.

3. Long duration of action: The action time in the body is as long as 8 hours, while the action time of thrombolytic drugs applied clinically in the body is mostly 20 to 30 minutes.

4. Safe and side effect-free: Unlike most thrombolytic drugs, nattokinase does not hydrolyze plasma fibrinogen but acts directly on cross-linked fibrin, thus avoiding the risk of inducing bleeding.

Anzyme® Fermented soybean extract, containing the active ingredient nattokinase, is a stable alkaline serine protease produced through the fermentation of Bacillus subtilis natto. With its stable enzyme activity, pure natto flavor, and characteristic color, it is formulated into capsules, tablets, powders, solid beverages, chewable candies, and gel candies, tailored to meet the demands of thrombolytic health products.

About Annzyme®:

Annzyme is a new brand for Angel enzymes products. We are dedicated to providing customers with perfect solutions in many fields like baking, proteolysis, nucleic acid hydrolysis, starch further-processing etc, and already built highly automated production lines for enzymes and other biological products. We are committed to become the best enzymes supplier and service provider.

Press contact:

Angel Yeast Co., Ltd.

Address: 168 Chengdong Avenue, Yichang, Hubei, P. R. China

Tel: +86-717-6369520

Fax: +86-717-6370680

Email: lili@angelyeast.com